✦ LIBER ✦

EFFECT OF THE SPECIFIC SRC KINASE INHIBITOR AZD0530 ON OSTEOLYTIC LESIONS IN PROSTATE CANCER

✍ Scribed by Yang, Joy C; Bai, Lanfang; Kung, Hsing-Jien; Evans, Christopher P

Book ID: 122098300
Publisher: Lippincott Williams and Wilkins
Year: 2008
Tongue: English
Weight: 125 KB
Volume: 179
Category: Article
ISSN: 0022-5347
DOI: 10.1016/S0022-5347(08)61145-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

585 POSTER The dual specific Src/Abl kin

585 POSTER The dual specific Src/Abl kinase inhibitor AZD0530 inhibits in vitro growth and induces apoptosis in non-small cell lung cancer lines

✍ B. Helfrich; B. Frederick; D. Raben; P.A. Bunn 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 60 KB

50 POSTER Inhibition of Src kinase with

50 POSTER Inhibition of Src kinase with the dual Src/Abl kinase inhibitor AZD0503 reduces bladder tumour growth and the development of mixed osteolytic/osteosclerotic lesions in bone

✍ E.D. Williams; E.W. Thompson; D. Sreedharan; T.P. Green 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 88 KB

391 POSTER A Phase I randomized trial to

391 POSTER A Phase I randomized trial to assess the effects of Src inhibitor AZD0530 on renal function in healthy volunteers

✍ R. Chetty; N. Dalton; M. Rimmer; N. Cockburn; I. Smith; A. Swaisland; J. Hargrea 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Effects of the Src kinase inhibitor sara

Effects of the Src kinase inhibitor saracatinib (AZD0530) on bone turnover in healthy men: A randomized, double-blind, placebo-controlled, multiple-ascending-dose phase I trial

✍ Rosemary A Hannon; Glen Clack; Martin Rimmer; Alan Swaisland; J Andrew Lockton; 📂 Article 📅 2010 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 243 KB

Erratum: Effects of the Src kinase inhib

Erratum: Effects of the Src kinase inhibitor saracatinib (AZD0530) on bone turnover in healthy men: A randomized, double-blind, placebo-controlled, multiple-ascending-dose phase I trial

✍ Rosemary A Hannon; Glen Clack; Martin Rimmer; Alan Swaisland; J Andrew Lockton; 📂 Article 📅 2012 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 31 KB

A phase II, randomized, open-label, pilo

A phase II, randomized, open-label, pilot study to evaluate the safety and the effects on bone resorption of saracatinib (AZD0530) in patients with prostate cancer or breast cancer with metastatic bone disease

✍ M. Aklilu*; A. Hussain; C.P. Evans; R.A. Hannon; A. Lipton; M. Dimairo; J. Yu; P 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 56 KB